This is just a text.
On behalf of the Organizing Committee of APASL STC Islamabad 2019, it is my great pleasure to welcome all the participants across the country and from abroad to attend the esteemed Conference on Viral Hepatitis from December 5-8, 2019 at Serena Hotel Islamabad, Pakistan. The theme of the meeting is Elimination of Viral Hepatitis by 2030 “From Dream to Reality”.
It is indeed an honor that PSSLD will be holding Third APASL Single Topic Conference this year. PSSLD is working with clear objective to create awareness among health care workers and to sensitize them to the burden of Liver diseases and its implications in the community.
The meeting’s content and activities are tailored to a wide audience of Hepatologists, Gastroenterologists, General practitioners and Postgraduate students. In this meeting we have included several interactive sessions with live audience response. Scientific program has CME credits and offers fantastic updates for consultants, trainees and primary care physicians. Faculty will include international key opinion leaders, mainly from the Asia Pacific region as well as from home.
We urge our colleagues to participate enthusiastically and honor us with their presence. This will be an exciting and educational meet for all.
All the committees are working very hard to make it a memorable event. It would be a great opportunity to meet and network with like-minded colleagues.
It will be winter in Islamabad which is surrounded by Margalla Hills and you will need warm clothing if you intend to move around. Remains of ancient civilization of Ghandara (Taxila) are just nearby (45 minutes’ drive) and if you wish to have a trip to snow covered mountains it is just 40 Km away.
Looking forward to welcome you all in the beautiful city of Islamabad.
Prof. Masood Siddiq
Chair Organizing Committee
Here is our event schedule
It is indeed an honor that PSSLD will be holding APASL Single Topic Conference this year. We are pleased and honored to inform our esteemed colleagues and participants that a four-day conference on “Elimination of Hepatitis from Dream to Reality” will be held on Dec 5-8, 2019.
The official language of the conference is English, simultaneous translation will not be provided.
In December temperature in Islamabad range from 2C – 24C.
The time zone in Pakistan is Greenwich Mean Time (GMT) + 5 hour.
The Pakistan monetary system is Rupee. Foreign currency may be changed at banks during normal banking hours (09:00-16:00), or hotels, airports and in exchange offices. All major credit cards are acceptable in most hotels, restaurants and shops.
The organizer is not able to take any responsibility whatsoever for injury or damage involving persons and property during the meeting. Participants are advised to take out their own personal travel and health insurance for their trip.
A personal letter of invitation can be sent to the participants on request.
Participants are requested to check with the Pakistani embassy/consulate in their home country or with their travel agency for visa requirements. It is the responsibility of the participant to obtain a visa if required.
Business lunches and coffee/tea during breaks (as indicated in the program) are included in the registration fee.
Pakistan International Airline is the national airline which operates in all major European, North American and Asian countries. Other airlines operating in Pakistan are: Emirates Airline, Gulf Airlines, Qatar Airlines, Etihad Airlines, British Airlines, Turkish Airlines, Royal Thai Airline Malaysian Airlines, Air China and Thai United.
Serena Hotel Islamabad: Khayaban-e-Suhrwardy, G-5, Islamabad.
Phone: (+92- 51) 2874000.
Marriott Hotel Islamabad: Agha Khan Rd, F-5/1 Shalimar 5 Islamabad.
Phone: (+92- 51) 2826121
Lai Wei is a Professor of Hepatology & Medicine, and is the Director of Peking University Hepatology Institute since 2004 and Chief of Department of Hepatology at Peking University People’s Hospital since 2001. His current research interests involve antiviral treatment of hepatitis B and C. Dr. Wei is the President of the Chinese Society of Hepatology. He served to develop the Chinese Guideline for Management of Hepatitis B, and Management, Diagnosis and Prevention of Hepatitis C virus Infection. In addition, Dr Wei is involved in Kidney Disease Improving Global Outcome to develop a Guideline for HCV Infection, Diagnosis, Prevention and Management in Kidney Disease and contributes to APASL for hepatitis C guideline.
Dr Tehami is a consultant gastroenterologist who specialises in hepatology and hepatobiliary medicine. He joined UHS in August 2018. He previously worked as a consultant hepatologist at Shrewsbury and Telford Hospitals NHS Trust for over three years before joining UHS.
He looks after patients with a wide range of hepatopancreaticobiliary (HPC) problems, but has a specialist interest in HPB endoscopy (ERCP/EUS). His clinical role is divided into inpatient ward work, outpatient clinics and endoscopy lists.
Dr Tehami's main clinical interests are HPB medicine and endoscopy, endoscopy teaching and training, and improving patient care through education of other health professionals and service development.
Below is a selection of Dr Tehami's most recent publications:
Professor Xiaoyuan Xu graduated from thre First Hospital of Lanzhou Medical College in 1988. He is currently a chief of the institue of infectious disease,Peking University.Professor Xu is also a vice chief of the Department of Infectious Disease,Peking Unicersity First Hospital.
Professor Xu is a standing committee member of the Liver Disease Association of China; a vice chairman of the Liver Disease Association of Beijing,China;a vice leader of the Group of AIDS,Infectious Disease Association of China;a membership of Chinesee Medical Association.Profeesor Xu is editor of National Medical Jornal of China;Chinese Journal of Hepatology;Clinical Internal Medicine Journal of China and World Chinese Journal of Digestology.Professor Xu has published 80 papers about HIV/AIDS/HBV/HCV/SARS.
Prof. Duan is the Vice President of Beijing Youan Hospital Capital Medical University and President of Chinese Society of Hepatology, Chinese Medical Association. He is also the director of Translational Hepatology Institute of Capital Medical University and Director of Liver Division of Wu Jieping Medical Foundation. He is a Co-chief Editor of Journal of Clinical Hepatology and Chinese Journal of Gastroenterology and Hepatology. He has been the Chairman of Chinese Severe Liver Diseases Meeting (2007-2018).
Prof. Duan has been awarded Beijing Science and Technology Progress Prize, Chinese Medical Science and Technology Prize, Wu Jieping Prize for Medical Innovation; Science and Technology Progress Prize of Hebei Province and National Prize for Progress in Science and Technology.
He received his doctor;s degree from Capital Medical University, Beijing China and finished his postdoctorial training at Klinikum Benjamin Franklin, Free University of Berlin, Germany. His clinical interests include the chronic viral hepatitis, autoimmune and cholestatic liver diseases. His main research work includes the pathogenesis and treatment of l liver fibrosis.
He is the President-Elect of IAS, Past President of APASL (2009-2010) and Immediate Past President of the Chinese Society of Hepatology. He currently serves China Foundation of Viral Hepatitis Prevention and Control as vice president, and CEVHAP as Executive Council Member. He also serves as associate editor for Journal of Gastroenterology & Hepatology and Hepatology International.
Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia. He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care and public health policy for 20 years. He has developed extensive national and international collaborations, and is internationally recognized in the areas of HCV natural history and epidemiology, therapeutic strategies for acute and chronic HCV infection, particularly among people who inject drugs, and HCV elimination strategies.
Professor Dore established the St Vincent’s Hospital viral hepatitis service in 1999, and has led its development into one of the leading national and international hepatitis C treatment services, with a particular focus on marginalised populations including people who inject drugs and homeless persons.
Major Category 1 Grants
Professor Jinlin Hou is the Director and Professor of the Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Professor Hou is the president of APASL 2017 and the president of Chinese Medical Association of Infectious Diseases（2013-2016. Professor Hou joined the University Department of Medicine of Nanfang Hospital in July 1984. Between 1993 and 1994,he received training in the Department of Medicine at St. Mary’s Hospital Medical School in London, UK. Between 2000 and 2001, Professor Hou was a visiting Fellow at the Institute of Hepatology, London, UK. He has been invited to deliver talks at both national and international liver conferences owing to his expertise in viral hepatitis and other liver diseases. His current research interests include the clinical management of liver and Infectious Diseases and the molecular virology and immunology of hepatitis virus infection. He has published more than 500 articles in both national and international journals, including GUT, Hepatology, Journal of Immunology,Journal of Hepatology, Science，LANCET Infect Dis, NEJM et al.
I was born in 1952 in the Senirkent district of Isparta. I finished primary and secondary school here. In 1976, I graduated from Ankara University Faculty of Medicine. About a week after my graduation, I became an assistant in the Department of Internal Medicine at the same faculty. Between 1983-85, I specialized in Gastroenterology and in 1985 I became an assistant professor in Ankara University Faculty of Medicine, Department of Gastroenterology. I went to Japan in 1985 and studied at Tokyo Women's Medical Collage on diagnostic endoscopy, endoscopic ultrasonography and endoscopic interventions. I returned from Japan at the end of 1986. I became an associate professor in 1988. In 1990, with a scholarship from TUBITAK, I also worked in Tokyo National Cancer Center for 4 months on endoscopy, cytology and histepatology of early gastric cancer. I became a professor in 1994. In 1999, I worked for a month at the Cleveland Clinic in Miami to improve my knowledge and experience. I am still working in Ankara University Faculty of Medicine Department of Gastroenterology. In September 2006, I was elected as the Head of the Internal Medicine Department of our faculty.
Dr. Bilal Hameed is specialist who cares for patients with liver disease. His expertise includes providing care before and after liver transplantation.
Hameed earned his medical degree at Dow University of Health Sciences in Pakistan and completed an internal medicine residency at the University of Minnesota. He completed a fellowship in gastroenterology at the University of Minnesota and a fellowship in transplant hepatology at UCSF.
In addition to authoring numerous peer-reviewed articles, Hameed has received many awards and honors in his field. He is a member of the American Association for the Study of Liver Diseases, American Gastroenterological Association and American Society of Transplantation.
Professor Salimur Rahman is a veteran Hepatologist of Bangladesh and at present working as professor of hepatology Bangabandhu Sheikh Mujib Medical University which is the only medical university of this country. He is one of the founders of the discipline in this country. He is a co-editor of 1) ‘Liver: A Complete Book on HepatoPancreato-Biliary Diseases’ and 2) ‘Comprehensive Text Book of Hepatitis B’ published by Elsevier and Jaypee respectively. Professor Rahman has over 100 publications in international and regional journals. He is Editor-in-Chief of Euroasian Journal of Hepato-Gastroenterolgy, the official publication of Euroasian Gastroenterological Association and Viral Hepatitis Foundation Bangladesh. He is the current President of Association for the Study of the Liver, Dhaka, Bangladesh – the national association of Hepatologists of the country and the Senior VicePresident of Association of Physicians of Bangladesh – the premier platform of specialist physicians of Bangladesh. He is also the founder Chairman of Viral Hepatitis Foundation Bangladesh. He served as member national committee for Hepatitis B virus in Bangladesh and presently serving as executive committee member of Asian Pacific Association for the study of the Liver (APASL). He is the current president of South Asian Association for the Study of Liver (SAASL). Professor Salimur Rahman is a leading interventionist of Bangladesh and has pioneered the transformation of Hepatology from a theoretical to an interventional super-specialty in this country. He is a senior faculty member of the Department of Hepatology, Bangabandhu Sheikh Mujib Medical University. He is a Fellow of Bangladesh College of Physicians and Surgeons, Royal College of Physicians of Edinburgh and Royal College of Physicians of Dublin.
Prof. Wasim Jafri
Prof. Masood Siddiq
Abstract should be developed according to following format and should not be of more than 250 words. Last date for Abstract Submission is October 31, 2019